Hossein Sabet-Sarvestani
Research Subjects
Research Interests
Hossein Sabet-Sarvestani has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Hossein Eshghi
Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
23 shared publications - Mohammad Izadyar
Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
11 shared publications Nazanin Noroozi-Shad
Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
9 shared publicationsMehdi Bakavoli
4 shared publicationsMohammad Izadyar
Department of Chemistry, Faculty of Science, Ferdowsi University of Mashhad, Mashhad, Iran
4 shared publications- Ali Shiri
Department of Chemistry, Faculty of Science Ferdowsi University of Mashhad Mashhad Iran
3 shared publications
Latest Publications
- 24 November 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (44)
Design, Synthesis, In Silico Evaluation, and Biological Assessment of Novel Pyrido[2,3‐d]Pyrimidine Derivatives as Potential Anticancer Agents
Aim: This research aimed to design and synthesize pyrido[2,3‐d]pyrimidine derivatives ( 7a–l ) with possible anticancer properties, targeting the epidermal growth factor receptor (EGFR) in prostate cancer. Methods and results: A new series of pyrido[2,3‐d]pyrimidine derivatives ( 7a–l ) were synthesized in high yields by refluxing intermediate 6 , obtained through a two‐step process, with various aromatic aldehydes in glacial acetic acid, and were characterized by FTIR, 1 H nuclear magnetic resonance (NMR), 13 C NMR, and mass spectrometry. Molecular docking simulations were carried out to assess the binding energy and interaction of these compounds with EGFR, which is overexpressed in prostate cancer cells. Based on docking results, Compounds 7d , 7f , 7k , 7a , and 7h were selected for cytotoxicity testing on PC‐3 prostate cancer cells. Compound 7d , with the best docking score (−10.38 kcal/mol), exhibited the strongest anticancer effect, with inhibitory concentration (IC 50 ) values of 43.78, 37.13, and 32.92 µM at 24, 48, and 72 h, respectively, compared to doxorubicin with an IC 50 ≈ 2 µM. Additionally, Compounds 7a , 7f , 7h , and 7k showed moderate to low activity, with IC 50 values ranging from 70 to 160 µM at 48 h. Compound 7d showed a selectivity index (SI) between 1 and 2 when tested on normal NIH/3T3 cells. Mechanistic studies indicated that 7d induced G1 phase cell cycle arrest and apoptosis in PC‐3 cells. In silico ADMET analysis also predicted favorable pharmacokinetic properties for Compounds ( 7a–l ). Conclusion: According to in silico and in vitro findings, Compound 7d showed promising anticancer potential for prostate cancer. Nevertheless, more preclinical research is necessary, including in vivo validation and kinase inhibition assays, to confirm EGFR‐target engagement, and evaluate the therapeutic potential of Compound 7d .
- 24 November 2025
- Published by Wiley in ChemistrySelect
- Vol. 10 (44)
Design, Synthesis, In Silico Evaluation, and Biological Assessment of Novel Pyrido[2,3‐d]Pyrimidine Derivatives as Potential Anticancer Agents
Aim: This research aimed to design and synthesize pyrido[2,3‐d]pyrimidine derivatives ( 7a–l ) with possible anticancer properties, targeting the epidermal growth factor receptor (EGFR) in prostate cancer. Methods and results: A new series of pyrido[2,3‐d]pyrimidine derivatives ( 7a–l ) were synthesized in high yields by refluxing intermediate 6 , obtained through a two‐step process, with various aromatic aldehydes in glacial acetic acid, and were characterized by FTIR, 1 H nuclear magnetic resonance (NMR), 13 C NMR, and mass spectrometry. Molecular docking simulations were carried out to assess the binding energy and interaction of these compounds with EGFR, which is overexpressed in prostate cancer cells. Based on docking results, Compounds 7d , 7f , 7k , 7a , and 7h were selected for cytotoxicity testing on PC‐3 prostate cancer cells. Compound 7d , with the best docking score (−10.38 kcal/mol), exhibited the strongest anticancer effect, with inhibitory concentration (IC 50 ) values of 43.78, 37.13, and 32.92 µM at 24, 48, and 72 h, respectively, compared to doxorubicin with an IC 50 ≈ 2 µM. Additionally, Compounds 7a , 7f , 7h , and 7k showed moderate to low activity, with IC 50 values ranging from 70 to 160 µM at 48 h. Compound 7d showed a selectivity index (SI) between 1 and 2 when tested on normal NIH/3T3 cells. Mechanistic studies indicated that 7d induced G1 phase cell cycle arrest and apoptosis in PC‐3 cells. In silico ADMET analysis also predicted favorable pharmacokinetic properties for Compounds ( 7a–l ). Conclusion: According to in silico and in vitro findings, Compound 7d showed promising anticancer potential for prostate cancer. Nevertheless, more preclinical research is necessary, including in vivo validation and kinase inhibition assays, to confirm EGFR‐target engagement, and evaluate the therapeutic potential of Compound 7d .
- 24 November 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (46) , 20239-20253
π-Delocalization and aromaticity as key factors in regioselective ring closure of fused triazolopyrimidines: an experimental–theoretical approach
This study presents a comprehensive synthetic and computational investigation of the regioselective ring-closing reactions in the synthesis of three pyrazolo[4,3- e ][1,2,4]triazolo[4,3- a ]pyrimidine (PTP) derivatives, namely 3-H, 3-Me, and 3-Et.
- 24 November 2025
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 49 (46) , 20239-20253
π-Delocalization and aromaticity as key factors in regioselective ring closure of fused triazolopyrimidines: an experimental–theoretical approach
This study presents a comprehensive synthetic and computational investigation of the regioselective ring-closing reactions in the synthesis of three pyrazolo[4,3- e ][1,2,4]triazolo[4,3- a ]pyrimidine (PTP) derivatives, namely 3-H, 3-Me, and 3-Et.
- Open Access
- 22 April 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (17) , 12917-12930
Exploring CO2 activation mechanisms with triphenylphosphine derivatives: insights from energy decomposition and deformation density analyses
Developing mechanistic study in CO2 transformations via energy decomposition and deformation density analyses.
- 22 April 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 15 (17) , 12917-12930
Open AccessExploring CO2 activation mechanisms with triphenylphosphine derivatives: insights from energy decomposition and deformation density analyses
Developing mechanistic study in CO2 transformations via energy decomposition and deformation density analyses.
- 24 March 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (17) , 3982-4005
Single-atom molecular editing: transformative advances in carbocyclic and heterocyclic frameworks
Single-atom editing (contraction, expansion, deletion, and insertion) precisely modifies cyclic frameworks, enabling step-efficient synthesis of drugs, natural products, and advanced materials.
- 24 March 2025
- Published by Royal Society of Chemistry (RSC) in Organic & Biomolecular Chemistry
- Vol. 23 (17) , 3982-4005
Single-atom molecular editing: transformative advances in carbocyclic and heterocyclic frameworks
Single-atom editing (contraction, expansion, deletion, and insertion) precisely modifies cyclic frameworks, enabling step-efficient synthesis of drugs, natural products, and advanced materials.
- Open Access
- 12 September 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (40) , 29122-29133
Design and synthesis of novel main protease inhibitors of COVID-19: quinoxalino[2,1- b ]quinazolin-12-ones
Aiming to discover potent inhibitors targeting 3CL pro , an efficient procedure has been established for the synthesis of novel quinoxalino[2,1- b ]quinazolin-12-ones.
- 12 September 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (40) , 29122-29133
Open AccessDesign and synthesis of novel main protease inhibitors of COVID-19: quinoxalino[2,1- b ]quinazolin-12-ones
Aiming to discover potent inhibitors targeting 3CL pro , an efficient procedure has been established for the synthesis of novel quinoxalino[2,1- b ]quinazolin-12-ones.
- 30 July 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (33) , 14791-14800
Quinoxaline derivatives as potent compounds against both 3CLpro and PLpro enzymes of SARS-CoV-2 virus: an insight from experimental and theoretical approaches
Inspired by favipiravir, new quinoxaline derivatives were synthesized to study possible compounds as inhibitors of SARS-CoV-2's cysteine proteases, including 3CLpro and PLpro.
- 30 July 2024
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 48 (33) , 14791-14800
Quinoxaline derivatives as potent compounds against both 3CLpro and PLpro enzymes of SARS-CoV-2 virus: an insight from experimental and theoretical approaches
Inspired by favipiravir, new quinoxaline derivatives were synthesized to study possible compounds as inhibitors of SARS-CoV-2's cysteine proteases, including 3CLpro and PLpro.
- 8 November 2023
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 47 (46) , 21253-21263
Distortion-controlled 1,2-dicarbene reactivity of 3-triflyloxybenzynes: a theoretical approach
A high reactivity of 3-triflyloxybenzynes in the macrocyclization reaction with tetrahydrofuran (THF) was recently reported by Cheng et al. and it was analyzed by our group using DFT calculations. We found that the transformation proceeds through an overlooked pathway arising from 1,2-dicarbene reactivity and via the intermediacy of a de-aromatized cyclic allene and not the ortho-triflyloxy aryl anion suggested by Cheng et al. The 1,2-dicarbene reactivity of the arynes was proved using natural bond orbital, electron localization function, and frontier orbital analysis. The stability of various 1,2-dicarbene-type benzynes was determined by two key factors, first, the spatial extent of the donating orbital on the C2 atom which is dependent on the π-donation ability of the substituents, and second, the electron occupancy of the orbital which is in turn dependent on the σ-donation ability of the substituents. The reactivity of various 3-triflyloxybenzynes were found to be dependent on the distortion magnitude required to reach the transition state.
- 8 November 2023
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 47 (46) , 21253-21263
Distortion-controlled 1,2-dicarbene reactivity of 3-triflyloxybenzynes: a theoretical approach
A high reactivity of 3-triflyloxybenzynes in the macrocyclization reaction with tetrahydrofuran (THF) was recently reported by Cheng et al. and it was analyzed by our group using DFT calculations. We found that the transformation proceeds through an overlooked pathway arising from 1,2-dicarbene reactivity and via the intermediacy of a de-aromatized cyclic allene and not the ortho-triflyloxy aryl anion suggested by Cheng et al. The 1,2-dicarbene reactivity of the arynes was proved using natural bond orbital, electron localization function, and frontier orbital analysis. The stability of various 1,2-dicarbene-type benzynes was determined by two key factors, first, the spatial extent of the donating orbital on the C2 atom which is dependent on the π-donation ability of the substituents, and second, the electron occupancy of the orbital which is in turn dependent on the σ-donation ability of the substituents. The reactivity of various 3-triflyloxybenzynes were found to be dependent on the distortion magnitude required to reach the transition state.